DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/37c6ca/aids_related_can) has announced the addition of Global Markets Direct's new report "Aids - Related Cancers - Pipeline Review, Q4 2010" to their offering.
Aids - Related Cancers - Pipeline Review, Q4 2010
This report provides information on the therapeutic development for Aids - Related Cancers , complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Aids - Related Cancers . Aids - Related Cancers -Pipeline Review 2010, Q4 2010 is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team.
Scope
- A snapshot of the global therapeutic scenario for Aids - Related Cancers .
- A review of the Aids - Related Cancers products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Aids - Related Cancers pipeline on the basis of therapeutic class, route of administration and molecule type.
- Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.
Reasons to buy
- A snapshot of the global therapeutic scenario for Aids - Related Cancers .
- A review of the Aids - Related Cancers products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Aids - Related Cancers pipeline on the basis of therapeutic class, route of administration and molecule type.
- Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.
Key Topics Covered:
- Aids - Related Cancers Overview
- Therapeutics Development
- An Overview of Pipeline Products for Aids - Related Cancers
- Aids - Related Cancers Therapeutics under Development by Companies
- Aids - Related Cancers Therapeutics under Investigation by Universities/Institutes
- Companies Involved in Aids - Related Cancers Therapeutics Development
- Universities/Institutes Involved in Aids - Related Cancers Therapeutics Development
- Aids - Related Cancers Therapeutics Assessment
- Assessment by Monotherapy Products
- Assessment by Combination Products
- Assessment by Route of Administration
- Assessment by Molecule Type
- Late Stage Drug Profiles - Universities/Institutes
- DaunoXome - Drug Profile
- Doxil - Drug Profile
- R&D Progress
For more information visit http://www.researchandmarkets.com/research/37c6ca/aids_related_can